These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 36291706)

  • 1. Drug-Disease Association Prediction Using Heterogeneous Networks for Computational Drug Repositioning.
    Kim Y; Jung YS; Park JH; Kim SJ; Cho YR
    Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational drug repositioning with attention walking.
    Park JH; Cho YR
    Sci Rep; 2024 May; 14(1):10072. PubMed ID: 38698208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative benchmarking and evaluation framework for heterogeneous network-based drug repositioning methods.
    Li Y; Yang Y; Tong Z; Wang Y; Mi Q; Bai M; Liang G; Li B; Shu K
    Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38647153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Repositioning Based on Deep Sparse Autoencoder and Drug-Disease Similarity.
    Lei S; Lei X; Chen M; Pan Y
    Interdiscip Sci; 2024 Mar; 16(1):160-175. PubMed ID: 38103130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HINGRL: predicting drug-disease associations with graph representation learning on heterogeneous information networks.
    Zhao BW; Hu L; You ZH; Wang L; Su XR
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34891172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational drug repositioning using low-rank matrix approximation and randomized algorithms.
    Luo H; Li M; Wang S; Liu Q; Li Y; Wang J
    Bioinformatics; 2018 Jun; 34(11):1904-1912. PubMed ID: 29365057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational drug repositioning based on multi-similarities bilinear matrix factorization.
    Yang M; Wu G; Zhao Q; Li Y; Wang J
    Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33147616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NetPro: Neighborhood Interaction-Based Drug Repositioning via Label Propagation.
    Huang Y; Bin Y; Zeng P; Lan W; Zhong C
    IEEE/ACM Trans Comput Biol Bioinform; 2023; 20(3):2159-2169. PubMed ID: 37018341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of various protein similarities using random forest technique to infer augmented drug-protein matrix for enhancing drug-disease association prediction.
    Kitsiranuwat S; Suratanee A; Plaimas K
    Sci Prog; 2022; 105(3):368504221109215. PubMed ID: 35801312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm.
    Luo H; Wang J; Li M; Luo J; Peng X; Wu FX; Pan Y
    Bioinformatics; 2016 Sep; 32(17):2664-71. PubMed ID: 27153662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SNF-NN: computational method to predict drug-disease interactions using similarity network fusion and neural networks.
    Jarada TN; Rokne JG; Alhajj R
    BMC Bioinformatics; 2021 Jan; 22(1):28. PubMed ID: 33482713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational drug repositioning using meta-path-based semantic network analysis.
    Tian Z; Teng Z; Cheng S; Guo M
    BMC Syst Biol; 2018 Dec; 12(Suppl 9):134. PubMed ID: 30598084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NEDD: a network embedding based method for predicting drug-disease associations.
    Zhou R; Lu Z; Luo H; Xiang J; Zeng M; Li M
    BMC Bioinformatics; 2020 Sep; 21(Suppl 13):387. PubMed ID: 32938396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inferring new indications for approved drugs via random walk on drug-disease heterogenous networks.
    Liu H; Song Y; Guan J; Luo L; Zhuang Z
    BMC Bioinformatics; 2016 Dec; 17(Suppl 17):539. PubMed ID: 28155639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additional Neural Matrix Factorization model for computational drug repositioning.
    Yang X; Zamit L; Liu Y; He J
    BMC Bioinformatics; 2019 Aug; 20(1):423. PubMed ID: 31412762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug repositioning based on residual attention network and free multiscale adversarial training.
    Li G; Li S; Liang C; Xiao Q; Luo J
    BMC Bioinformatics; 2024 Aug; 25(1):261. PubMed ID: 39118000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting drug-disease interactions by semi-supervised graph cut algorithm and three-layer data integration.
    Wu G; Liu J; Wang C
    BMC Med Genomics; 2017 Dec; 10(Suppl 5):79. PubMed ID: 29297383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting Drug-Gene-Disease Associations by Tensor Decomposition for Network-Based Computational Drug Repositioning.
    Kim Y; Cho YR
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A two-tiered unsupervised clustering approach for drug repositioning through heterogeneous data integration.
    Hameed PN; Verspoor K; Kusljic S; Halgamuge S
    BMC Bioinformatics; 2018 Apr; 19(1):129. PubMed ID: 29642848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating Biological Networks for Drug Target Prediction and Prioritization.
    Ji X; Freudenberg JM; Agarwal P
    Methods Mol Biol; 2019; 1903():203-218. PubMed ID: 30547444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.